Jane Osbourn
individual
About
Jane Osbourn OBE FMedSci PhD is a British biotechnologist and biotech executive best known for antibody discovery and development work spanning Cambridge Antibody Technology, MedImmune/AstraZeneca, and Alchemab Therapeutics. As of September 2025, Alchemab lists her as Chief Executive Officer, while SV Health Investors lists her as a Venture Partner. She has also served as chair of the UK BioIndustry Association and held board/advisory roles across the Cambridge life-sciences ecosystem.
Areas of interest
biotechantibody therapeuticsdrug discoveryneurodegenerationoncologyAI-enabled drug discoverylife sciencescell therapySTEMbiotech ecosystem development